Biotech · Public company · Cambridge, MA, US
Parabilis Medicines, Inc.
Ticker PBLS · SEC CIK 0001657677
Track this companyFree. Adds Parabilis Medicines, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline5
- BevacizumabPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- FOG-001Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- mFOLFOX-6Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Trifluridine/tipiracilPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- FOG-001 in Locally Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started May 23, 2023ClinicalTrials.gov NCT05919264 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 25, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 424B4 · 424B4SEC EDGAR · filed Jun 10, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Jun 9, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Jun 4, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed May 27, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed May 19, 2026 · fetched Nov 12, 2026